| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratory of Molecular Pharmacology, Division of Cancer Treatment, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892
In order to understand the cellular events associated with cell death after the formation of topoisomerase II-DNA cleavable complexes, we compared the induction of endonucleolytic DNA fragmentation by etoposide and its more potent analog, teniposide (VM-26) in the human cell lines HT-29 and HL-60. A new filter-binding assay is described, which allows rapid quantification of nonprotein-linked DNA fragmentation involved in apoptosis. Both cell lines showed similar loss of colony formation ability following 30 min of treatment with various VM-26 concentrations even though the initial topoisomerase II-mediated DNA single-strand break frequency was higher in HL-60 cells. DNA repair studies following drug removal indicated that VM-26-induced DNA breaks reversed rapidly and completely in HT-29 cells, while in HL-60 cells, the initial lesions persisted at and above 5 µM VM-26. In both cell lines, topoisomerase II cleavage complexes, as measured by DNA-protein cross-links by alkaline elution, reversed rapidly and completely within 2–3 h. Secondary DNA fragmentation resembling chromatin endonucleolytic cleavage by apoptosis could be detected in HL-60 cells 3 h after VM-26 or etoposide treatment but not in HT-29 cells. Secondary DNA fragmentation was also induced in the human colon cancer cell lines COLO 320, which have c-myc amplification. Since HL-60 cells also have c-myc amplification and HT-29 do not, it is possible that c-myc over-expression may be involved in secondary DNA fragmentation. Finally, our results indicate heterogeneity of cell death mechanisms after exposure to topoisomerase II inhibitors among human cancer cell lines.
1 Recipient of fellowship support from the National Cancer Institute of Canada.
2 To whom requests for reprints should be addressed, at Bldg 37, Rm 5C27, Bethesda, MD 20892.
Received 3/ 1/91. Accepted 9/24/91.
This article has been cited by other articles:
|
|
 |
|
  S. Bergeron, M. Beauchemin, and R. Bertrand Camptothecin- and etoposide-induced apoptosis in human leukemia cells is independent of cell death receptor-3 and -4 aggregation but accelerates tumor necrosis factor-related apoptosis-inducing ligand-mediated cell death Mol. Cancer Ther., December 1, 2004; 3(12): 1659 - 1669. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Russo, D. Arzani, S. Trombino, and C. Falugi c-myc Down-Regulation Induces Apoptosis in Human Cancer Cell Lines Exposed to RPR-115135 (C31H29NO4), a Non-Peptidomimetic Farnesyltransferase Inhibitor J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 37 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Droin, F. Bichat, C. Rebe, A. Wotawa, O. Sordet, A. Hammann, R. Bertrand, and E. Solary Involvement of caspase-2 long isoform in Fas-mediated cell death of human leukemic cells Blood, March 15, 2001; 97(6): 1835 - 1844. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Marshansky, X. Wang, R. Bertrand, H. Luo, W. Duguid, G. Chinnadurai, N. Kanaan, M. D. Vu, and J. Wu Proteasomes Modulate Balance Among Proapoptotic and Antiapoptotic Bcl-2 Family Members and Compromise Functioning of the Electron Transport Chain in Leukemic Cells J. Immunol., March 1, 2001; 166(5): 3130 - 3142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Rodriguez-Lopez, D. Xenaki, T. O. B. Eden, J. A. Hickman, and C. M. Chresta MDM2 Mediated Nuclear Exclusion of p53 Attenuates Etoposide-Induced Apoptosis in Neuroblastoma Cells Mol. Pharmacol., January 1, 2001; 59(1): 135 - 143. [Abstract] [Full Text]
|
|
|
|
 |
|
 N. Droin, M. Beauchemin, E. Solary, and R. Bertrand Identification of a Caspase-2 Isoform that Behaves as an Endogenous Inhibitor of the Caspase Cascade Cancer Res., December 1, 2000; 60(24): 7039 - 7047. [Abstract] [Full Text]
|
|
|
|
|
|
P. A. Svingen, J. E. Karp, S. Krajewski, P. W. Mesner Jr, S. D. Gore, P. J. Burke, J. C. Reed, Y. A. Lazebnik, and S. H. Kaufmann Evaluation of Apaf-1 and procaspases-2, -3, -7, -8, and -9 as potential prognostic markers in acute leukemia Blood, December 1, 2000; 96(12): 3922 - 3931. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-T. Sane and R. Bertrand Caspase Inhibition in Camptothecin-treated U-937 Cells Is Coupled with a Shift from Apoptosis to Transient G1 Arrest Followed by Necrotic Cell Death Cancer Res., August 1, 1999; 59(15): 3565 - 3569. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ishiyama, M. Hiroe, T. Nishikawa, T. Shimojo, S. Abe, H. Fujisaki, H. Ito, K. Yamakawa, N. Kobayashi, T. Kasajima, et al. The Fas/Fas Ligand System Is Involved in the Pathogenesis of Autoimmune Myocarditis in Rats J. Immunol., November 1, 1998; 161(9): 4695 - 4701. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L Garcia-Bermejo, C Perez, N. Vilaboa, E de Blas, and P Aller cAMP increasing agents attenuate the generation of apoptosis by etoposide in promonocytic leukemia cells J. Cell Sci., January 3, 1998; 111(5): 637 - 644. [Abstract] [PDF]
|
|
|
|
|
|
L. A. Parsels, R. C. Zellars, T. L. Loney, J. D. Parsels, M. F. Clarke, A. K. Merchant, T. S. Lawrence, and J. Maybaum Prevention of Fluorodeoxyuridine-Induced Cytotoxicity and DNA Damage in HT29 Colon Carcinoma Cells by Conditional Expression of Wild-Type p53 Phenotype Mol. Pharmacol., October 1, 1997; 52(4): 600 - 605. [Abstract] [Full Text]
|
|
|
|
|
|
C. M. Eischen, T. J. Kottke, L. M. Martins, G. S. Basi, J. S. Tung, W. C. Earnshaw, P. J. Leibson, and S. H. Kaufmann Comparison of Apoptosis in Wild-Type and Fas-Resistant Cells: Chemotherapy-Induced Apoptosis Is Not Dependent on Fas/Fas Ligand Interactions Blood, August 1, 1997; 90(3): 935 - 943. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Boland, S. J. Foster, and L. A. J. O'Neill Daunorubicin Activates NFkappa B and Induces kappa B-dependent Gene Expression in HL-60 Promyelocytic and Jurkat T Lymphoma Cells J. Biol. Chem., May 16, 1997; 272(20): 12952 - 12960. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Morse-Gaudio and M. Risley Topoisomerase II expression and VM-26 induction of DNA breaks during spermatogenesis in Xenopus laevis J. Cell Sci., January 10, 1994; 107(10): 2887 - 2898. [Abstract] [PDF]
|
|
|
|
|
|
G. Bicknell, R. Snowden, and G. Cohen Formation of high molecular mass DNA fragments is a marker of apoptosis in the human leukaemic cell line, U937 J. Cell Sci., January 9, 1994; 107(9): 2483 - 2489. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
